A Penn State-led team has developed a rapid syphilis test using multilayer nanoparticles, achieving up to 46% stronger signal intensity and enabling single-step detection of low antibody titers.
A new blood biomarker ratio using neutrophil CD64 and monocyte CD169 demonstrated 100% sensitivity and 96.6% specificity for distinguishing bacterial from viral infections in febrile infants, according to study data presented at EEMC 2024.
A University of Washington study found the panel cross-reacts with 78 gut bacteria species, resulting in over 250,000 false-positive norovirus results since 2019.
Alveo Technologies and UTMB have partnered to develop point-of-care diagnostics for Lassa fever, deploying molecular sensing platforms at clinical sites in Nigeria and Sierra Leone to support real-time pathogen detection.
The 21-month clinical research study with Imperial College London will assess the diagnostic value of a lateral flow test for active neutrophil elastase.
Roche has launched two new research PCR assays for Cyclospora cayetanensis detection, expanding lab testing options amid a US outbreak and adding flexibility for gastrointestinal pathogen research.
A Quest Diagnostics study of 1.5 million women found those with bacterial vaginosis are over three times more likely to have a non-viral STI, highlighting the need for comprehensive diagnostic testing.